KRAS and colorectal carcinoma: In a carefully performed, retrospective study including 743 CRC, de Roock and co-workers describe in KRAS wild-type tumors a significant association of objective response, overall survival, and progression free survival in exon 20 but not in exon 9 mutated tumors (22).